# Ampersand Biosciences LLC

Canonical: https://abierto.us/vendors/ampersand-biosciences-llc-hlwqxlfm7jr8

- UEI: HLWQXLFM7JR8
- CAGE: 79VC0
- Location: Lake Clear, NY
- Awards in window: 3 (5 transactions), $1,684,811 obligated, August 27, 2024 to April 9, 2026

## Awarding agencies

- National Institutes of Health: 3 awards, $1,684,811

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $1,684,811

## Competition

- Full and Open Competition: 3 awards

## Solicitations won

- Multiplexed Nucleic Acid Self-Test for Reproducible and Sensitive HIV Detection (PHS-2025-1), $2,566,049. https://abierto.us/opportunities/phs20251

## Largest awards

- 75N93024C00087 (definitive contract): $1,084,824, National Institutes of Health Niaid. Further Characterization and Validation of Monoclonal Antibodies to Study Respiratory. https://www.usaspending.gov/award/CONT_AWD_75N93024C00087_7529_-NONE-_-NONE-/
- 75N93025C00018 (definitive contract): $599,987, National Institutes of Health Niaid. Development of Monoclonal Antibodies to Chemokines in the Ferret Model of Respiratory Disease.. https://www.usaspending.gov/award/CONT_AWD_75N93025C00018_7529_-NONE-_-NONE-/
- 75N93022C00044 (definitive contract): $0, National Institutes of Health Niaid. SBIR Topic 107 Reagents for Immunologic Analysis of Non- Mammalian and Underrepresented Mammalian Models. https://www.usaspending.gov/award/CONT_AWD_75N93022C00044_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/ampersand-biosciences-llc-hlwqxlfm7jr8.